Nonetheless, this inhibitory effect on the Nav1.5 peak current might synergize with the inhibition of hERG K+ channels and potentiate the prolongation of the QTc-interval, increasing the risk of development of fatal arrhythmias like TdP. The gene discussed is SCN5A; the disease is torsades de pointes.